Renasant Corporation (RNST)
Official siteFINANCIAL SERVICES • BANKS - REGIONAL • NYSE
Market Cap: $3.63B
Last updated: Nov 17, 2026 at 11:05 AM ET
Renasant Corporation (RNST) Stock Forecast
Analysts expect Renasant (RNST) to earn $3.67 per share in the fiscal year ending Dec 31, 2026, on revenue of $1.12B. Of 7 analysts, 6 rate the stock Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 4 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 7 ratings average 1.71, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 86% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 3 | 42.9% |
| Buy | 3 | 42.9% |
| Hold | 1 | 14.3% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 7
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 6.8% and revenue estimates rise 8.0%.
- Fiscal year ending Dec 31, 2026
- $3.67
- EPS consensus, revenue $1.12B
- Fiscal year ending Dec 31, 2027
- $3.92
- EPS consensus, revenue $1.21B
- Next report
- Jan 25, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $3.67 | $3.64 to $3.69 | 7 | $1.12B | $1.12B to $1.12B | 6 |
| Dec 31, 2027 | $3.92 | $3.76 to $4.04 | 6 | $1.21B | $1.20B to $1.22B | 5 |
Quarterly Estimates
The EPS consensus falls from $0.95 for the quarter ending Dec 31, 2026 to $0.91 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.95 | $0.88 to $1.03 | 9 | $288.78M | $275.87M to $299.88M | 8 |
| Mar 31, 2027 | $0.91 | $0.82 to $0.99 | 6 | $287.05M | $280.70M to $293.26M | 5 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 3 upward and 10 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 4 |
| Fiscal year ending Dec 31, 2027 | 2 | 4 |
| Quarter ending Mar 31, 2027 | 1 | 2 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 2.9% from $3.78.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $3.67 | $3.78 | $3.79 | $3.78 | $3.78 | -3.0% |
| Fiscal year ending Dec 31, 2027 | $3.92 | $3.92 | $3.90 | $3.90 | $3.93 | -0.3% |
| Quarter ending Mar 31, 2027 | $0.91 | $0.94 | $0.94 | $0.94 | $0.94 | -3.2% |
Frequently Asked Questions About RNST
What is the RNST stock forecast?
Consensus analyst estimates put Renasant's EPS at $3.67 for the fiscal year ending Dec 31, 2026, on revenue of $1.12B. The consensus rating from 7 analysts is Buy.
How do analysts rate RNST stock?
Of 7 analysts covering Renasant, 3 rate it Strong Buy, 3 Buy, 1 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from RNST next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $3.67, with estimates from $3.64 to $3.69 from 7 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $3.92, with estimates from $3.76 to $4.04 from 6 analysts.
What revenue do analysts expect from Renasant next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $1.12B, with estimates from $1.12B to $1.12B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $1.21B, with estimates from $1.20B to $1.22B.
How many analysts cover RNST?
7 analysts rate Renasant stock, and 7 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
RNST pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors